立方体不耐受,Evolocumab治疗高脂血症和心律失常:从一个具有挑战性的临床情景中吸取教训
Matthew M Balocco1,2, Rockib Uddin3, Sara P Dimeo1,2,4
1Emergency Medicine, Creighton University School of Medicine, Phoenix, USA.
Cureus
|December 17, 2025
概括
一名接受PCSK9抑制剂埃沃洛库马布治疗的患者出现了新发性心房动 (AF). 这一案例强调了在接受PCSK9抑制剂治疗的复杂患者中对罕见心脏事件的监测的重要性.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 像evolocumab这样的PCSK9抑制剂对于无法耐受他类药物的患者至关重要.
- 一位78岁的女性患有广泛的心血管疾病和他类药物不耐受,需要非他类药物脂质治疗.
研究的目的:
- 报告和检查一个罕见的心脏事件,新发动的心房动 (AF),在接受evolocumab.
- 讨论PCSK9抑制剂治疗的潜在促成因素和临床考虑.
主要方法:
- 一个患有多种并发病症的患者在evolocumab.com上的病例报告.
- 在开始PCSK9抑制剂治疗后,对心律和临床状况的监测.
主要成果:
- 患者在开始使用evolocumab四周后出现了新的心房动 (AF) 与快速心室反应.
- 治疗涉及节拍控制,抗凝血剂和心脏起器植入;埃沃洛库马布在没有复发的AF的情况下恢复使用.
结论:
- 虽然没有确定的关联被确立,但这一案例强调了对PCSK9抑制剂潜在的不常见心脏影响的警的需要.
- 密切监测罕见的心脏事件对于接受evolocumab治疗的复杂患者至关重要.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Coronary Artery Disease V: Interprofessional Care
203
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203
Atherosclerosis IV: Nursing Management
346
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
346
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.2K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.2K
Myocarditis III: Medical Management
160
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
160


